Neurotech International

Neurotech International Neurotech is a biopharmaceutical company focused on the development and commercialisation of neurological solutions that improve quality of life.

Our current focus is the ground-breaking NTI164 treatment in children with neurological disorders. Our current development program is a world-first clinical trial using NTI164 to treat Paediatric Autism Spectrum Disorder (ASD) at Monash Children’s Hospital, Melbourne. Phase I/II trial results demonstrated successful outcomes relating to the safety, tolerability and efficacy of NTI164 on key behavioural parameters with 93% of participants showing symptom improvement.

Address

Perth, WA

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61893893130

Website

Alerts

Be the first to know and let us send you an email when Neurotech International posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Neurotech International:

Shortcuts

Share

Category